PMC:7126544 / 63181-63370
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T516 | 92-100 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T517 | 92-96 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T518 | 149-157 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T54351 | 0-2 | Chemical | denotes | Lu | http://purl.obolibrary.org/obo/CHEBI_33382 |
T36207 | 17-27 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T63318 | 135-145 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T502 | 0-189 | Sentence | denotes | Lu reported that remdesivir may have the greatest potential for the successful treatment of SARS-CoV-2, but the efficacy and safety of remdesivir in COVID-19 needs further evaluation [135]. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1650 | 92-102 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1654 | 17-27 | Chemical | denotes | remdesivir | MESH:C000606551 |
1655 | 135-145 | Chemical | denotes | remdesivir | MESH:C000606551 |
1664 | 149-157 | Disease | denotes | COVID-19 | MESH:C000657245 |